 Fibrinolytic Agents
"Fibrinolytic Agents" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Fibrinolysin or agents that convert plasminogen to FIBRINOLYSIN.
| Descriptor ID |
D005343
|
| MeSH Number(s) |
D27.505.519.421.750 D27.505.954.411.320 D27.505.954.502.427
|
| Concept/Terms |
|
Below are MeSH descriptors whose meaning is more general than "Fibrinolytic Agents".
Below are MeSH descriptors whose meaning is more specific than "Fibrinolytic Agents".
This graph shows the total number of publications written about "Fibrinolytic Agents" by people in this website by year, and whether "Fibrinolytic Agents" was a major or minor topic of these publications.
To see the data from this visualization as text, click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1997 | 1 | 0 | 1 | | 1998 | 3 | 2 | 5 | | 1999 | 1 | 0 | 1 | | 2000 | 2 | 0 | 2 | | 2001 | 1 | 2 | 3 | | 2002 | 2 | 0 | 2 | | 2003 | 2 | 0 | 2 | | 2005 | 1 | 4 | 5 | | 2006 | 5 | 3 | 8 | | 2007 | 2 | 1 | 3 | | 2008 | 0 | 2 | 2 | | 2009 | 6 | 4 | 10 | | 2010 | 4 | 0 | 4 | | 2011 | 6 | 5 | 11 | | 2012 | 6 | 3 | 9 | | 2013 | 6 | 3 | 9 | | 2014 | 8 | 7 | 15 | | 2015 | 4 | 3 | 7 | | 2016 | 7 | 2 | 9 | | 2017 | 10 | 2 | 12 | | 2018 | 7 | 5 | 12 | | 2019 | 4 | 1 | 5 | | 2020 | 12 | 3 | 15 | | 2021 | 4 | 8 | 12 | | 2022 | 3 | 11 | 14 | | 2023 | 1 | 8 | 9 | | 2024 | 5 | 6 | 11 | | 2025 | 10 | 2 | 12 | | 2026 | 8 | 2 | 10 |
To return to the timeline, click here.
Below are the most recent publications written about "Fibrinolytic Agents" by people in Profiles.
-
Kiskaddon AL, Johnson PN, Dallas L, Stang C, Beckman E, Gattis S, Smith C, Pingle J, Butchin J, Ordons KJ, Amankwah EK, Witt DM, Rech MA, Goldenberg NA. Pharmacist antithrombotic interventions in critically ill children: A multicenter prospective study. Am J Health Syst Pharm. 2026 Oct 23; 83(21):e853-e859.
-
Nygaard RM, Colonna E, Poole A, Faucher LD, Paine RE, Sangji N, Lacey A, Bhavsar D, Colling K, Armour A, Fleming I, Wiktor A, Wibbenmeyer L. Synthesis of Protocols for Frostbite Care From the FROST Study Sites. J Burn Care Res. 2026 09 08; 47(5):1405-1425.
-
Blair KJ, Hawley KL, Burlew CC. Management of carotid artery injuries: What you need to know. J Trauma Acute Care Surg. 2026 Nov 01; 101(5):723-735.
-
Kartika T, Buitrago L, Li J, Cunningham-Rundles C, Coller BS. Comparison of variably specific Bruton tyrosine kinase inhibitors on platelet aggregation mediated by Fc? receptor (Fc?R) IIa, glycoprotein VI, and platelet endothelial aggregation receptor (PEAR) 1: implications for Bruton tyrosine kinase inhibitors as antithrombotic therapy. Res Pract Thromb Haemost. 2026 Jul; 10(5):106841.
-
Aboul-Nour H, Siegler JE, Thompson SL, Glover PA, Daniel JA, Penckofer M, Smith MM, Yaghi S, Ro J, Chen L, D'Souza M, Khasiyev F, Kerrigan D, Sharma R, Aziz YN, Kirchhoffer K, Kam W, Melkumova E, Sloane KL, Lineback CM, Thottempudi N, Heaton S, Linares G, Singh E, Almallouhi E, Stretz C, Albert Fernandez CJ, Dumitrascu OM, Culbertson CJ, Elangovan C, Bowman A, Valhuerdi Porto C, Chahien D, Herpich F, Farooqui M, Kang J, de Havenon A, Nelson A, Shahrivari M, Stamm B, Khezri N, Lewis S, Sathya A, Leung LY, Eklund K, Rojas-Soto D, Nedelcu S, Al Kasab S, Van Coevering RJ, Thon J, Jillella DV, Nahab FB. Real-World Practice in Secondary Stroke Prevention Following Embolic Stroke of Undetermined Source: Secondary Analysis of the CASPR Registry. Neurol Clin Pract. 2026 Aug; 16(4):e200631.
-
Singh N, Strbian D, Vatanpour S, Field TS, Yu AYX, Ganesh A, Barber PA, Choi PMC, Buck BH, Kleinig TJ, Campbell B, Molina C, Muir KW, Hill MD, Coutts SB. Association of Successful Recanalization and Functional Outcomes in Minor Ischemic Stroke With Proven Occlusion: A Secondary Analysis of TEMPO-2 Trial. Stroke. 2026 Aug; 57(8):2305-2314.
-
Nathan M, Kiskaddon AL, Emani S, Bigelow AM, Callahan RM, Cleveland JD, Federman M, Ma M, McMullan DM, Mir A, Branstetter J, VanderPluym C, Yerebakan C. 2026 American Association for Thoracic Surgery (AATS) expert consensus statement: Antithrombotic management of neonates/infants undergoing cardiac interventions. J Thorac Cardiovasc Surg. 2026 09; 172(3):618-662.e7.
-
Goldenberg NA, Berkowitz SD, Betensky M, Holzhauer S, Ignjatovic V, Kiskaddon A, Schaufelberger D, Monagle P, Male C. Development of new antithrombotic drugs for children (part 1): guidance from the ISTH SSC Subcommittee on Pediatric and Neonatal Thrombosis and Hemostasis and the Pedi-ATLAS Group. J Thromb Haemost. 2026 09; 24(9):3360-3368.
-
Massicotte S, Vatanpour S, Doolan C, Zhang J, Ganesh A, Choi PMC, Buck BH, Field TS, Yu AYX, Kleinig TJ, Muir KW, Campbell BCV, Molina CA, Appireddy R, Hill MD, Singh N, Coutts SB. Intracranial Hemorrhage Patterns and Outcomes in Minor Stroke: Analysis of the TEMPO-2 Trial. Stroke. 2026 Jun; 57(6):1526-1534.
-
Navi BB, Wang M, Yamal JM, Rajan SS, Czap AL, Parker SA, Nour M, Spokoyny I, Mir S, Fink ME, Willey JZ, Jones WJ, Grotta JC. Potential Missed Opportunities to Administer Intravenous Thrombolysis to Patients With Acute Ischemic Stroke. Stroke. 2026 Mar; 57(3):633-640.
|
People  People who have written about this concept. _
Similar Concepts
People who have written about this concept.
_
Top Journals
Top journals in which articles about this concept have been published.
|